Product
Supplier
Encyclopedia
Inquiry
Pazopanib buy - large image1
Pazopanib buy - image1

Pazopanib

3 Inquiries

Unit Price: Get Latest Price
CAS No.:

444731-52-6

Grade:

medical grade

Content:

98%

Brand:

Jinlan

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-03-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,API,Intermediate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Pazopanib (444731-52-6)


    • CAS Number: 444731-52-6
    • Chemical Name: 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
    • Molecular Formula: C₂₁H₂₃N₇O₂S
    • Molecular Weight: 437.52 g/mol
    • EINECS Number: 600-642-6
    • Synonyms: Votrient®, GW786034,
    • Related Categories: Multi-targeted Receptor Tyrosine Kinase Inhibitor (TKI), VEGFR/PDGFR/c-Kit Inhibitor, Oral Small Molecule Inhibitor, Solid Tumor Therapeutic
    • Key Highlight: Potent oral multi-targeted TKI inhibiting VEGFR1-3, PDGFRα/β and c-Kit; indicated for advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS); blocks tumor angiogenesis and cell proliferation with favorable oral bioavailability.

    Basic Info
    Product Name:

    Pazopanib

    Other Name:

    Benzenesulfonamide,5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide;Pazopanib;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;GW 786034;Votrient;AE 941;790713-33-6

    CAS No.:

    444731-52-6

    Molecular Formula:

    C21H23N7O2S

    InChIKeys:

    InChIKey=CUIHSIWYWATEQL-UHFFFAOYSA-N

    Molecular Weight:

    437.518

    Exact Mass:

    437.52

    UNII:

    7RN5DR86CK

    NSC Number:

    752782

    DSSTox ID:

    DTXSID8048733

    NCI Thesaurus Code:

    C74547

    ATC Code:

    L01XE11|L - Antineoplastic and immunomodulating agents

    HScode:

    29350090

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    127.41000

    XLogP3:

    3.1

    Density:

    1.4±0.1 g/cm3

    Melting Point:

    285-289°C (dec.)

    Boiling Point:

    728.8±70.0 °C at 760 mmHg

    Flash Point:

    394.6±35.7 °C

    Refractive Index:

    1.702

    Water Solubility:

    In water, 3.3 mg/L at 25 deg C (est)

    Storage Conditions:

    Store at room temperature between 20 deg C and 25 deg C (68 deg F to 77 deg F); excursions permitted to 15 deg C to 30 deg C (59 deg F to 86 deg F).

    Vapor Pressure:

    3.21X10-14 mm Hg at 25 deg C (est)

    Henrys Law Constant:

    Henry's Law constant = 1.10X10-15 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    pKa1 = 2.29 (amine); pKa2 = 5.07 (amine); pKa3 = 10.41 (amide) (est)

    Experimental Properties:

    White to slightly yellow solid. Practically insoluble above pH 4 in aqueous media/Pazopanib hydrochloride/|Hydroxyl radical reaction rate constant = 4.02X10-10 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,API,Intermediate

    Location:

    Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1

    Payment Terms:

    100% TT in advance

    Average lead Time:

    275

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2020

    Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd (with its export company Hangzhou Royall Import & Export Co.,Ltd.) is located in Hangzhou, Zhejiang Province. Neighboring Ningbo port, Shanghai port, Hangzhou Xiaoshan Int' l Airport and Shanghai Pudong Int' l Airport, the transportation and production environment are excellent. JINLAN PHARMA mainly business includes: 1) API, Pharmaceutical Intermediates, CMO, CRO, CDMO and so on. 2) Pharmaceutical Equipment such as: Distilled Water Machinery, Mixer, Sterilizer and so on.

    JINLAN PHARM focus on:

    ■ Contrast Agent

    ■ Anti-COVID APIs

    ■ Respiratory System APIs

    ■ Anti-tumor & Anti-Cancer APIs

    ■ Anti-Diabetes APIs

    ■ Anti-HCV & Anti-HBV APIs

    ■ Anti-HIV APIs

    ■ Peptides

    ■ Pharmaceutical Intermediates

    ■ CMO, CRO, CDMO

  • Inquiry History
    3 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Pazopanib

    0.1 G Sep 8, 2023
    Bangladesh

    Pazopanib

    10 KG Apr 1, 2026
    Turkey

    Pazopanib indazol

    60 KG Mar 31, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.